Osteosarcoma, with poor survival after metastasis, is considered the most common primary
bone cancer in adolescents. Notwithstanding the efforts of researchers, its five-year survival …

Cancer immunotherapy and vaccine development have significantly improved the fight
against cancers. Despite these advancements, challenges remain, particularly in the clinical …

Tumor immunotherapy based on immune checkpoint blockade (ICB) still suffers from low
host response rate and non‐specific distribution of immune checkpoint inhibitors, greatly …

Nanomaterials have been extensively used for cancer therapy and diagnosis due to their
designability, multifunctionality, and unique in vivo distribution. Metal ions are increasingly …

Melanoma, the most aggressive form of cutaneous malignancy arising from melanocytes, is
frequently characterized by metastasis. Despite considerable progress in melanoma …

Photothermal therapy (PTT) is an effective treatment modality that is highly selective for
tumor suppression and is a hopeful alternative to traditional cancer therapy. However, PTT …

Although immunotherapy has a broad clinical application prospect, it is still hindered by low
immune responses and immunosuppressive tumor microenvironment. Herein, a simple and …

The multidisciplinary approaches in treatment of cancer appear to be essential in term of
bringing benefits of several disciplines and their coordination in tumor elimination. Because …

Programmed cell death (PCD, mainly including apoptosis, necrosis, ferroptosis, pyroptosis,
and autophagy) and immunogenic cell death (ICD), as important cell death mechanisms, are …

Glioma is characterized by highly invasive, progressive, and lethal features. In addition,
conventional treatments have been poorly effective in treating glioma. To overcome this …